OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AVIR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Atea Pharmaceuticals (AVIR) Earnings Date & Reports

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVIR is expected to report earnings to rise 115.91% to -94 cents per share on November 06

Atea Pharmaceuticals AVIR Stock Earnings Reports

Q3'25

Est.

$-0.95

Q2'25

Missed

by $0.03

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.05

Q3'24

Beat

by $0.06

The last earnings report on August 07 showed earnings per share of -43 cents, missing the estimate of -40 cents. With 108.45K shares outstanding, the current market capitalization sits at 289.26M.

View a ticker or compare two or three

Compare

AVIR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AVIR
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVIR showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of vaccines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 Franklin Street

Phone

+1 857 284-8891

Employees

Web

https://www.ateapharma.com